Performance of Meloxicam Niosomal Gel Formulations for Transdermal Drug Delivery

Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 12, Issue 2

Abstract

Niosomes have been reported as a possible approach to improve low skin permeation shown by conventional vehicles. In this study, a noisome-based delivery system of meloxicam (MX) was developed and characterized for in vitro performance. Niosomes were prepared by reverse-phase evaporation method (REV) using different non ionic surfactants and cholesterol in different molar ratios (1:1, 2:1, 3:1,1: 2 and 1:3) and different drug loading (5, 10 and 15 mg). The used surfactants included Tweens (20, 40 and 80), Brij (35 and 58) and Myrj 52. The prepared systems were characterized for entrapment efficiency, and in-vitro release. Accordingly, selected systems were evaluated for vesicle size, and formulated into different hydrogel bases (sodium carboxymethyl cellulose, hydroxypropyl cellulose, and sodium alginate). In-vitro drug release from the different formulations was studied over a period of 8 hr. Effect of formulation additives on drug release was also investigated. The anti-inflammatory activity of the selected formulations was evaluated by the paw edema test. Results showed high encapsulation efficiency which ranged from about 81.93% to 99.23%. The highest entrapment efficiency was obtained with 1:1 surfactant: cholesterol ratio and 15 mg drug loading, so niosomes prepared by this ratio were selected for further studies. Particle size ranged from 4.047 to 12.334 µm for different niosomal systems. In vitro drug release from different gel formulations containing 0.3% MX was compared to that from the same formulations containing 0.3% niosomally entrapped drug. In all formulations the drug release was more sustained in case of niosomally entrapped drug. Incorporation of glycerol and propylene glycol as formulation additives into gel formulations markedly enhanced the drug release, but the release from gels containing niosomally entrapped drug was still delayed.

Authors and Affiliations

Ahmad Usama, Gihan Fetih, Tahani El-Faham

Keywords

Related Articles

A Questionnaire Survey for Prevalence of Medication Use in Dehradun District of Uttarakhand, India

A questionnaire survey was conducted among 200 medical store (drug-retailer working in authorized drug stores) for investigating the prevalence of use of medication in Dehradun district of Uttarakhand. Study revealed tha...

Effect of Ethanolic Extracts of Lemon Grass and Mango Bark on the Cerebral Astrocytes of Adult Wistar Rats

Aims: Lemon grass and mango bark serves as one of the medicinal plants used in Nigeria for the treatment of malaria by traditional herbalists. This study was designed to assess the effects of ethanolic extract of lemon g...

Fed Bioequivalence Studies for Immediate Release Drug Products: Beneficial or Wastage?

Aims: The present study was undertaken to understand the need of fed bioequivalence studies for immediate release pharmaceutical products and thereby evaluating the relative appropriateness of guidelines given by the Eur...

Potential Antioxidant and Anti-Proliferative Activities of Biologically Active Marine Algae Extracts

Background: Marine microorganisms such as algae were identified a rich sources of biologically active compounds. This study was designed to explore the in vitro antioxidant, anti-apoptotic and anti proliferative activiti...

Effects of High-concentratıon Oxygen Inhalation during Cesarean Section with Spinal Anesthesia on Lipid Peroxidation, Oxidant and Antioxidant Systems

Objective: The benefit of supplemental oxygen during elective Cesarean section under regional anesthesia is controversial. Methodology: In this study, parturients were randomized two groups, to breathe either room air (a...

Download PDF file
  • EP ID EP342095
  • DOI 10.9734/BJPR/2016/26985
  • Views 61
  • Downloads 0

How To Cite

Ahmad Usama, Gihan Fetih, Tahani El-Faham (2016). Performance of Meloxicam Niosomal Gel Formulations for Transdermal Drug Delivery. Journal of Pharmaceutical Research International, 12(2), 1-14. https://europub.co.uk/articles/-A-342095